Variant report
Variant | rs2417745 |
---|---|
Chromosome Location | chr12:10715012-10715013 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:10389063..10390009-chr12:10714674..10715483,2 | K562 | blood: | |
2 | chr12:10484283..10485072-chr12:10714510..10715568,4 | K562 | blood: | |
3 | chr12:10388060..10389289-chr12:10714524..10715522,5 | MCF-7 | breast: | |
4 | chr12:10713530..10716257-chr12:10762530..10764410,2 | MCF-7 | breast: | |
5 | chr12:10388138..10389062-chr12:10714617..10715220,3 | K562 | blood: | |
6 | chr12:10483978..10484906-chr12:10714545..10715159,3 | MCF-7 | breast: | |
7 | chr12:10484385..10484963-chr12:10714626..10715246,2 | MCF-7 | breast: | |
8 | chr12:10714679..10715464-chr12:10826841..10827362,2 | MCF-7 | breast: | |
9 | chr12:10714739..10715346-chr12:10902495..10903116,2 | K562 | blood: | |
10 | chr12:10305944..10306449-chr12:10714647..10715601,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000060140 | Chromatin interaction |
ENSG00000256888 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10734838 | 0.81[ASN][1000 genomes] |
rs10743910 | 0.81[ASN][1000 genomes] |
rs10772319 | 0.81[ASN][1000 genomes] |
rs10772321 | 0.81[ASN][1000 genomes] |
rs10772323 | 0.81[ASN][1000 genomes] |
rs10772326 | 0.81[ASN][1000 genomes] |
rs10772327 | 0.81[ASN][1000 genomes] |
rs10845161 | 0.81[JPT][hapmap] |
rs10845162 | 0.82[AFR][1000 genomes] |
rs10845165 | 0.93[AFR][1000 genomes] |
rs10845171 | 0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10845172 | 0.86[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs10845173 | 0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs10845175 | 0.81[JPT][hapmap] |
rs11053860 | 0.87[AFR][1000 genomes];0.87[AMR][1000 genomes];0.85[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs11053861 | 0.84[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11053868 | 0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11053869 | 0.81[ASN][1000 genomes] |
rs11053870 | 0.81[ASN][1000 genomes] |
rs11053874 | 0.96[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11611202 | 0.82[JPT][hapmap] |
rs12312462 | 0.80[AFR][1000 genomes];1.00[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12423957 | 0.82[JPT][hapmap] |
rs1915322 | 0.93[AFR][1000 genomes] |
rs1915323 | 0.89[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs2002157 | 0.81[JPT][hapmap] |
rs2125093 | 0.85[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2125096 | 0.89[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2168750 | 0.81[ASN][1000 genomes] |
rs2417746 | 0.95[JPT][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes] |
rs2417748 | 0.93[AFR][1000 genomes] |
rs2607883 | 0.95[JPT][hapmap] |
rs2607885 | 0.89[AFR][1000 genomes];0.99[AMR][1000 genomes];0.93[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2607886 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs2607887 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.93[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2607888 | 0.95[JPT][hapmap] |
rs2607889 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2607890 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2607891 | 0.96[CEU][hapmap];0.94[CHB][hapmap];1.00[JPT][hapmap];0.86[YRI][hapmap];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2607892 | 0.96[CEU][hapmap];0.94[CHB][hapmap];1.00[JPT][hapmap];0.95[YRI][hapmap];0.88[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2607893 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2607895 | 0.96[CEU][hapmap];0.94[CHB][hapmap];1.00[JPT][hapmap];0.94[YRI][hapmap];0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2607896 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2607898 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.95[YRI][hapmap];0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.93[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2682474 | 0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2682476 | 0.96[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.90[YRI][hapmap];0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs3816567 | 0.81[JPT][hapmap] |
rs3983544 | 0.86[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs3983545 | 0.81[ASN][1000 genomes] |
rs3983546 | 0.81[ASN][1000 genomes] |
rs4076336 | 0.83[ASN][1000 genomes] |
rs4237929 | 0.83[ASN][1000 genomes] |
rs4763552 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs4763559 | 0.81[ASN][1000 genomes] |
rs6488306 | 0.85[JPT][hapmap];0.82[ASN][1000 genomes] |
rs6488307 | 0.81[ASN][1000 genomes] |
rs7134658 | 0.81[ASN][1000 genomes] |
rs7134908 | 0.81[ASN][1000 genomes] |
rs7306285 | 0.81[ASN][1000 genomes] |
rs7358656 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7488589 | 1.00[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7953221 | 0.88[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7971934 | 0.81[ASN][1000 genomes] |
rs7978850 | 0.81[JPT][hapmap] |
rs7980411 | 0.81[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv898766 | chr12:10537269-10722585 | Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 22 gene(s) | inside rSNPs | diseases |
2 | nsv557459 | chr12:10560591-10729821 | Genic enhancers Enhancers ZNF genes & repeats Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 22 gene(s) | inside rSNPs | diseases |
3 | nsv898772 | chr12:10622047-10722585 | Flanking Active TSS Enhancers ZNF genes & repeats Weak transcription Active TSS Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
4 | nsv557479 | chr12:10644663-10729821 | Weak transcription Enhancers Active TSS Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
5 | nsv898773 | chr12:10660850-10722585 | Enhancers Active TSS Weak transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
6 | nsv898774 | chr12:10666025-10722585 | Enhancers Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
7 | nsv898775 | chr12:10668694-10735786 | Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
8 | nsv1039120 | chr12:10675930-10755446 | Weak transcription Active TSS Genic enhancers Enhancers Strong transcription ZNF genes & repeats Flanking Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
9 | nsv832329 | chr12:10677094-10845946 | Strong transcription Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 26 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:10710800-10724800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr12:10713200-10715400 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
3 | chr12:10714000-10716000 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
4 | chr12:10714000-10733200 | Weak transcription | Primary T cells from cord blood | blood |
5 | chr12:10714400-10717000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr12:10714600-10716000 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr12:10714600-10718400 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr12:10714800-10715400 | Enhancers | Primary T helper naive cells from peripheral blood | blood |